T Cell Subsets in HIV Infected Patients after Successful Combination Antiretroviral Therapy: Impact on Survival after 12 Years

Open Access

Peer-reviewed

Research Article

Frederikke Falkencrone Rönsholt ,

* E-mail: frederikkefr@gmail.com

Affiliation Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
⨯
Sisse Rye Ostrowski,

Affiliation Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark
⨯
Terese Lea Katzenstein,

Affiliation Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
⨯
Henrik Ullum,

Affiliation Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark
⨯
Jan Gerstoft

Affiliation Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
⨯

Reader Comments (0)

Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
HIV infections
Is the Subject Area "HIV infections" applicable to this article?

Thanks for your feedback.
Immune activation
Is the Subject Area "Immune activation" applicable to this article?

Thanks for your feedback.
AIDS
Is the Subject Area "AIDS" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Hepatitis C
Is the Subject Area "Hepatitis C" applicable to this article?

Thanks for your feedback.